Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293057 · ClinicalTrials.gov registry record · NA
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT02293057 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 132 participants.
The verdict
NCT02293057, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
Girls in the juvenile justice system have unique developmental pathways to drug use and co-occurring risk (e.g., HIV/STI) behaviors that have typically not been considered or tested in order to identify evidence-based gender-specific substance use treatment approaches for this population. This study will advance scientific knowledge and clinical practice in the drug treatment and public health fields by testing the efficacy of a pre-existing, widely disseminated gender-responsive substance use treatment (VOICES) on drug use and HIV/STI risk behavior outcomes for a broad range of substance using girls and young women (ages 12-24) who are at-risk for or already involved with the justice system.
Interventions
- BEHAVIORAL VOICES Group
- BEHAVIORAL Girl Health Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293057
The ClinicalTrials.gov registry entry for NCT02293057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VOICES Group is the first listed.
NCT02293057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293057 about?
NCT02293057 is a clinical study titled "Gender-Responsive Drug Use Treatment for Juvenile Justice Girls". Girls in the juvenile justice system have unique developmental pathways to drug use and co-occurring risk (e.g., HIV/STI) behaviors that have typically not been considered or tested in order to identify evidence-based gender-specific substance use treatment approaches for this population. This study...
What is the current status of trial NCT02293057?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2014-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02293057?
The interventions under investigation include: VOICES Group (BEHAVIORAL), Girl Health Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02293057?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.